The social stigma attached with tuberculosis (TB) is the prime reason why most patients prefer taking treatment from private doctors. The public health department, therefore, is unable to identify the actual number of TB patients in the state.

India, with its high tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) burden, has long been looking for an affordable, high-sensitivity test to be used in the most peripheral health facilities with least technical complexity, minimal infrastructure and training. To address the issue, the state health department has now come up with a cost-effective measure of using 'Make in India' initiative to identify TB cases.